WINTON GROUP Ltd Purchases 21,718 Shares of DocGo Inc. (NASDAQ:DCGO)

WINTON GROUP Ltd boosted its holdings in DocGo Inc. (NASDAQ:DCGO) by 40.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 75,610 shares of the company’s stock after acquiring an additional 21,718 shares during the quarter. WINTON GROUP Ltd owned 0.07% of DocGo worth $321,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the business. WCM Investment Management LLC lifted its holdings in shares of DocGo by 64.2% during the fourth quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company’s stock valued at $18,637,000 after purchasing an additional 1,687,100 shares in the last quarter. American Century Companies Inc. raised its position in DocGo by 490.3% in the 4th quarter. American Century Companies Inc. now owns 452,254 shares of the company’s stock worth $1,918,000 after buying an additional 375,637 shares during the last quarter. Harbor Capital Advisors Inc. lifted its stake in DocGo by 37.5% during the 4th quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company’s stock valued at $5,647,000 after acquiring an additional 363,391 shares during the period. First Eagle Investment Management LLC purchased a new stake in shares of DocGo during the 4th quarter valued at about $1,116,000. Finally, Raymond James Financial Inc. bought a new stake in shares of DocGo in the fourth quarter worth approximately $527,000. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DCGO. Stifel Nicolaus dropped their target price on shares of DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a report on Friday, February 28th. Deutsche Bank Aktiengesellschaft downgraded DocGo from a “buy” rating to a “hold” rating and dropped their price target for the stock from $5.00 to $2.85 in a research note on Friday, February 28th. Finally, Needham & Company LLC reduced their price objective on DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a research report on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $4.89.

DocGo Stock Performance

NASDAQ DCGO opened at $2.64 on Monday. The business’s fifty day moving average is $4.03 and its 200 day moving average is $3.92. DocGo Inc. has a fifty-two week low of $2.63 and a fifty-two week high of $5.68. The company has a market capitalization of $269.24 million, a PE ratio of 9.43, a price-to-earnings-growth ratio of 14.16 and a beta of 1.08.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.